CNS/Brain Cancer
From the Journals
Don’t delay: Cancer patients need both doses of COVID vaccine
For patients with cancer, immune response to the first dose of the Pfizer COVID-19 vaccine is reduced, and there is a need for a booster dose at...
Clinical Insights
mCODE: Improving data sharing to enhance cancer care
Conference Coverage
CAR-T in children branching out to solid tumors
From the Journals
Detailed glioblastoma map could lead to better treatment approaches
Clinical Insights
How has the pandemic affected rural and urban cancer patients?
Conference Coverage
CXR-Net: An AI-based diagnostic tool for COVID-19
The tool showed promise in a pilot study.
Conference Coverage
Asymptomatic screening for COVID-19 in cancer patients still debated
Less than 1% of cancer patients studied were COVID-19 positive on asymptomatic screening.
Conference Coverage
Managing cancer outpatients during the pandemic: Tips from MSKCC
MSKCC has established guiding principles on how to manage cancer patients during the pandemic.
From the Journals
Increased risk of meningioma with cyproterone acetate use
The European Medicines Agency recommended in February 2020 that drugs containing 10 mg or more of cyproterone acetate should only be used for...
Guidelines
COVID-19 vaccination in cancer patients: NCCN outlines priorities
Recommended timing of vaccination varies based on cancer and treatment type.
From the Journals
Immunotherapy response linked to low TMB in recurrent glioblastoma